Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
2006 2
2007 4
2008 5
2009 3
2010 2
2011 11
2012 8
2013 3
2014 22
2015 24
2016 20
2017 27
2018 26
2019 51
2020 39
2021 59
2022 69
2023 55
2024 69
2025 52

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

478 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for M. khomeini
Search for M. Khomeiri instead (2 results)
Long non-coding RNAs involved in retinoblastoma.
Nasrolahi A, Azizidoost S, Radoszkiewicz K, Najafi S, Ghaedrahmati F, Sheykhi-Sabzehpoush M, Poodineh J, Hajizadeh M, Anbiyaiee A, Farzaneh M, Feghhi M. Nasrolahi A, et al. J Cancer Res Clin Oncol. 2023 Jan;149(1):401-421. doi: 10.1007/s00432-022-04398-z. Epub 2022 Oct 28. J Cancer Res Clin Oncol. 2023. PMID: 36305946 Review.
m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis.
Ghadimi M, Mohammadpour Z, Dashti-Khavidaki S, Milajerdi A. Ghadimi M, et al. Eur J Clin Pharmacol. 2019 Nov;75(11):1471-1480. doi: 10.1007/s00228-019-02730-0. Epub 2019 Aug 3. Eur J Clin Pharmacol. 2019. PMID: 31377892
This study aimed to examine the association between m-TOR inhibitors and the risk of developing PCP in solid organ transplant (SOT) recipients. ...
This study aimed to examine the association between m-TOR inhibitors and the risk of developing PCP in solid organ transplant (SOT) r …
Doxorubicin-related cardiotoxicity: review of fundamental pathways of cardiovascular system injury.
Avagimyan A, Pogosova N, Kakturskiy L, Sheibani M, Challa A, Kogan E, Fogacci F, Mikhaleva L, Vandysheva R, Yakubovskaya M, Faggiano A, Carugo S, Urazova O, Jahanbin B, Lesovaya E, Polana S, Kirsanov K, Sattar Y, Trofimenko A, Demura T, Saghazadeh A, Koliakos G, Shafie D, Alizadehasl A, Cicero A, Costabel JP, Biondi-Zoccai G, Ottaviani G, Sarrafzadegan N. Avagimyan A, et al. Cardiovasc Pathol. 2024 Nov-Dec;73:107683. doi: 10.1016/j.carpath.2024.107683. Epub 2024 Aug 5. Cardiovasc Pathol. 2024. PMID: 39111556 Review.
Splenic vein aneurysm.
Gharabaghi MA, Yazdi NA, Abrishami Z, Amini S. Gharabaghi MA, et al. BMJ Case Rep. 2012 Feb 21;2012:bcr1020115007. doi: 10.1136/bcr.10.2011.5007. BMJ Case Rep. 2012. PMID: 22665464 Free PMC article. No abstract available.
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial.
Sahraian MA, Abolfazli R, Shaygannejad V, Ashtari F, Majdinasab N, Navardi S, Baghbanian SM, Sedighi B, Naser Moghadasi A, Nahayati MA, Ghalyanchi Langroodi H, Mohammadianinejad SE, Beladi Moghadam N, Ayromlou H, Nikseresht A, Ghiasian M, Razazian N, Asadollahzadeh E, Sabzvari A, Kafi H, Albooyeh S. Sahraian MA, et al. Sci Rep. 2024 Oct 22;14(1):24921. doi: 10.1038/s41598-024-75745-y. Sci Rep. 2024. PMID: 39438591 Free PMC article. Clinical Trial.
Worldwide Survey of COVID-19-Associated Arrhythmias.
Coromilas EJ, Kochav S, Goldenthal I, Biviano A, Garan H, Goldbarg S, Kim JH, Yeo I, Tracy C, Ayanian S, Akar J, Singh A, Jain S, Zimerman L, Pimentel M, Osswald S, Twerenbold R, Schaerli N, Crotti L, Fabbri D, Parati G, Li Y, Atienza F, Zatarain E, Tse G, Leung KSK, Guevara-Valdivia ME, Rivera-Santiago CA, Soejima K, De Filippo P, Ferrari P, Malanchini G, Kanagaratnam P, Khawaja S, Mikhail GW, Scanavacca M, Abrahão Hajjar L, Rizerio B, Sacilotto L, Mollazadeh R, Eslami M, Laleh Far V, Mattioli AV, Boriani G, Migliore F, Cipriani A, Donato F, Compagnucci P, Casella M, Dello Russo A, Coromilas J, Aboyme A, O'Brien CG, Rodriguez F, Wang PJ, Naniwadekar A, Moey M, Kow CS, Cheah WK, Auricchio A, Conte G, Hwang J, Han S, Lazzerini PE, Franchi F, Santoro A, Capecchi PL, Joglar JA, Rosenblatt AG, Zardini M, Bricoli S, Bonura R, Echarte-Morales J, Benito-González T, Minguito-Carazo C, Fernández-Vázquez F, Wan EY. Coromilas EJ, et al. Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458. doi: 10.1161/CIRCEP.120.009458. Epub 2021 Feb 7. Circ Arrhythm Electrophysiol. 2021. PMID: 33554620 Free PMC article.
Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated from HIV Seropositive Patients in Tehran Iran.
Feyisa SG, Rasoolinejad M, Hasan-Nejad M, Amini S, Hamzelou G, Kardan-Yamchi J, Kazemian H, Karami-Zarandi M, Feizabadi MM. Feyisa SG, et al. Curr HIV Res. 2021;19(4):295-303. doi: 10.2174/1570162X19666210226125335. Curr HIV Res. 2021. PMID: 33634760
OBJECTIVE: The objective is to determine the rate of transmission and drug-resistant M. tuberculosis (MTB) strains isolated from HIV seropositive patients in Tehran province, Iran. ...RESULTS: A 20 (9.2%) patients were culture-positive for M. tuberculosis and typed …
OBJECTIVE: The objective is to determine the rate of transmission and drug-resistant M. tuberculosis (MTB) strains isolated from HIV …
Unilateral sixth nerve palsy.
Sotoodehnia M, Safaei A, Rasooli F, Bahreini M. Sotoodehnia M, et al. Am J Emerg Med. 2017 Jun;35(6):934.e1-934.e2. doi: 10.1016/j.ajem.2016.12.028. Epub 2016 Dec 12. Am J Emerg Med. 2017. PMID: 28043726
Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease.
Hooshmand Gharabagh L, Shargh A, Mohammad Hosseini Azar MR, Esmaeili A. Hooshmand Gharabagh L, et al. Clin Res Hepatol Gastroenterol. 2024 Mar;48(3):102279. doi: 10.1016/j.clinre.2023.102279. Epub 2023 Dec 29. Clin Res Hepatol Gastroenterol. 2024. PMID: 38159676 Clinical Trial.
However, the greater reduction in waist circumference was observed in EMPA groups compared to PGZ (-4.4 2.39 vs -2.051.28, p<0.001), meanwhile weight and BMI decreased significantly only in the patients receiving EMPA (-5.78 3.6 kg vs 0.93 0.33 kg and -2.01 3.19 kg/m(2) …
However, the greater reduction in waist circumference was observed in EMPA groups compared to PGZ (-4.4 2.39 vs -2.051.28, p<0.001), mean …
478 results